Private investment firm Sarissa Capital Management of Greenwich, Conn., has taken a 6.2 percent stake in Cambridge-based Ariad Pharmaceuticals Inc. and plans to seek representation on the drug maker's board, according to a regulatory filing Tuesday.
http://www.boston.com/business/technology/2013/10/29/connecticut-investment-firm-takes-stake-ariad/whviBP3mmCCkfLkU8r9FwI/story.html
http://www.boston.com/business/technology/2013/10/29/connecticut-investment-firm-takes-stake-ariad/whviBP3mmCCkfLkU8r9FwI/story.html
No comments:
Post a Comment
Useful criticism, helpful links and corrections and general comments are always welcome at Greenwich Roundup. Generally only spam ads and posts with very foul language get censored.
Contact me directly at GreenwichRoundup@gmail.com if you have a suggestion or comment you don't want publicized (but tell me so in your email).
I look forward to publishing your opinions.
COMMENTING RULES: We encourage an open exchange of ideas in the Greenwich community, but we ask you to follow our guidelines. Basically, be civil, smart, on-topic and free from profanity. Don't say anything you wouldn't want your mother to read!